Why Is Alector ($ALEC) Stock Up +10.5% Today? (Find out why any stock moved today on Tickeron.) Alector (ALEC) shares rose roughly 10.5% to about $2.00 on Monday, versus a prior close of $1.81. The primary catalyst was an exclusive global licensing deal with Genentech, a member of the Roche Group, for Alector's AL050 Parkinson's disease program. The agreement includes a $100 million upfront payment and up to $1.17 billion in milestone payments, plus tiered royalties. Alector said the partnership extends its cash runway into 2029. Trading volume was extraordinarily elevated, running far above the stock's typical daily average. Investors are watching for further pipeline updates and whether the post-announcement rally holds through the close. $ARCT $EDIT $CRBU $VYGR